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A B S T R A C T
Mice homozygous for the human GRACILE syndrome mutation (Bcs1lc.A232G) display decreased respiratory chain
complex III activity, liver dysfunction, hypoglycemia, rapid loss of white adipose tissue and early death. To
assess the underlying mechanism of the lipodystrophy in homozygous mice (Bcs1lp.S78G), these and wild-type
control mice were subjected to a short 4-hour fast. The homozygotes had low baseline blood glucose values, but a
similar decrease in response to fasting as in wild-type mice, resulting in hypoglycemia in the majority. Despite
the already depleted glycogen and increased triacylglycerol content in the mutant livers, the mice responded to
fasting by further depletion and increase, respectively. Increased plasma free fatty acids (FAs) upon fasting
suggested normal capacity for mobilization of lipids from white adipose tissue into circulation. Strikingly,
however, serum glycerol concentration was not increased concomitantly with free FAs, suggesting its rapid
uptake into the liver and utilization for fuel or gluconeogenesis in the mutants. The mutant hepatocyte mi-
tochondria were capable of responding to fasting by appropriate morphological changes, as analyzed by electron
microscopy, and by increasing respiration. Mutants showed increased hepatic gene expression of major meta-
bolic controllers typically associated with fasting response (Ppargc1a, Fgf21, Cd36) already in the fed state,
suggesting a chronic starvation-like metabolic condition. Despite this, the mutant mice responded largely nor-
mally to fasting by increasing hepatic respiration and switching to FA utilization, indicating that the mechanisms
driving these adaptations are not compromised by the CIII dysfunction.
Summary statement: Bcs1l mutant mice with severe CIII deficiency, energy deprivation and post-weaning lipo-
lysis respond to fasting similarly to wild-type mice, suggesting largely normal systemic lipid mobilization and
utilization mechanisms.
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1. Introduction
Mitochondrial hepatopathies in newborn infants are rare and if
subtle might be undiagnosed [1]. One of the several etiologies is re-
spiratory chain (RC) complex III (CIII, ubiquinol-cytochrome c re-
ductase) dysfunction caused by mutations in the nuclear gene BCS1L
[2]. This gene encodes a protein (BCS1L), which is located in the inner
mitochondrial membrane and functions as a translocase facilitating the
assembly of Rieske iron-sulfur protein (RISP) into the pre-complex of
CIII resulting in a catalytically active complex [3,4]. More than twenty
mutations have been published causing a broad spectrum of clinical
phenotypes [3]. The most severe phenotype is GRACILE syndrome
(Fellman disease, OMIM 603358) caused by a homozygous point mu-
tation (c.A232G, p.Ser78Gly) enriched in the Finnish population [5,6].
The acronym depicts the characteristic clinical findings: fetal Growth
Restriction, Aminoaciduria due to proximal tubulopathy, Cholestasis,
Iron accumulation, Lactic acidosis and Early death [5]. Motivated by
the robust genotype-phenotype consistency [5,7], the Fellman group
produced a knock-in mouse model carrying this mutation (Bcs1lc.A232G)
[8], the first viable disease model of CIII dysfunction. The homozygous
mutant mice (Bcs1lp.S78G) are healthy until weaning, after which they
present with decreasing CIII activity, growth restriction, metabolic liver
dysfunction, renal tubulopathy, and a short life span [8,9], thus phe-
nocopying the human disorder [5,10]. CIII activity is not completely
abolished in organs investigated in the mutant mice, but decreased to
below 50% of controls in affected tissues (20%, 40%, 40% in liver,
hearth and kidney respectively) [8]. The rapid disease progression to
lethality at about one month of age in the C57BL/6JBomTac genetic
background [9,11] is likely due to the inability to maintain blood
glucose, resulting in lethal hypoglycemia.
The liver plays a central role in metabolism and ensures blood
glucose and lipid homeostasis to meet the fuel requirements of other
organs. In hepatocytes, two reciprocal pathways, glycolysis and glu-
coneogenesis, are responsible for glucose homeostasis. The main reg-
ulators of these opposing processes are hormones (insulin, glucagon and
cortisol), and intracellular metabolites such as ATP and acetyl-CoA that
is produced from β-oxidation. ATP and acetyl-CoA stimulate the ana-
bolic direction with acetyl-CoA being an activator of gluconeogenesis
[12]. During sudden food deprivation, hepatocytes release glucose
mainly by glycogenolysis, but also through gluconeogenesis [13]. Fatty
acid (FA) oxidation is considered critical during fasting for providing
ATP and NADH to facilitate hepatic gluconeogenesis, and acetyl-CoA
for ketogenesis if fasting progresses to prolonged starvation [14]. The
capacity of the liver to respond to rapid changes in nutrient availability
is dependent on a highly dynamic transcriptional regulatory network,
particularly peroxisome proliferator-activated receptor alfa (PPARα).
SIRT1, a nuclear NAD+-dependent protein deacetylase is an important
regulator of lipid homeostasis, especially FA oxidation. Increasing
NAD+ levels activate the sirtuins and have a positive effect on meta-
bolism in different model organisms [15,16]. SIRT1 can either repress
or activate the transcriptional activities of its target proteins (to which
NF-kB and PGC-1α belong), and thereby regulate metabolic and stress
pathways [17].
Crosstalk between liver and other organs, such as adipose tissue, is
fundamental for metabolic homeostasis. In response to fasting, adipose
tissue launches lipolysis leading to release of free FAs and glycerol into
circulation. These are taken up by the hepatocytes, in which FAs are
used for β-oxidation and/or triacylglycerol synthesis and their storage
in lipid droplets, and glycerol in the gluconeogenetic pathway con-
verted to glucose [18]. In skeletal muscles, glycogen and protein
breakdown takes place, thereby providing alanine and lactate for glu-
coneogenesis in the liver [13]. Lactate is metabolized to pyruvate, a
tricarboxylic acid (TCA) cycle substrate, but also used for gluconeo-
genesis in hepatocytes, which then release glucose for use in the muscle,
a feed-back system named Cori cycle [19].
In mitochondria, ATP is generated through oxidative
phosphorylation (OXPHOS), as the energy of reducing equivalents is
converted into a proton gradient driving the ATP synthase. Reducing
equivalents are supplied from the cytoplasmic glycolytic pathway, from
processes in the mitochondrial matrix (TCA cycle and β-oxidation). A
dysfunction in CIII not only results in energy deprivation due to de-
creased electron flow in RC but may also compromise supercomplex
(respirasome) formation [11] as CIII has a central role in their forma-
tion together with complex I and complex IV [20]. Respirasomes are
located in the planar part of cristae and have been suggested to enhance
electron flow and channeling of substrates [21,22].
Almost complete loss of white adipose tissue is a dramatic mani-
festation in both GRACILE syndrome patients and Bcs1lp.S78G mice
[5,8]. Concomitantly, the patients show hepatic steatosis and the mice
microvesicular fat accumulation in hepatocytes. Fat accumulation is not
seen in other tissues than liver, which suggests that it results from
normal mobilization of lipids from white adipose tissue to liver for fuel.
However, the basic lipid mobilization and transport in these mice have
never been investigated. Therefore, we subjected Bcs1lp.S78G mice at age
25–28 days (P25–28) to a short fast and measured hepatic and plasma
lipids and parameters of energy metabolism.
2. Materials and methods
2.1. Animals
The Bcs1lc.A232G mouse strain,> 99% congenic in C57BL/6JBomTac
background [9,11], was maintained on a rodent diet (Labfor R34,
Lantmännen, Stockholm, Sweden) in a vivarium with 12 h light/dark
cycles at 22 °C and water ad libitum [8]. Homozygous (Bcs1lp.S78G) and
littermate controls, either wild-type (WT) or heterozygous mice that are
phenotypically identical to WT, were weaned at postnatal day 19–21
(P19–21). Their health and weight were followed daily, as previously
described [9]. When the homozygotes showed signs of disease either as
weight reduction or behavioral changes (at P25–28), but well before
end-stage disease, they were randomized to a 4-hour fast or normally
fed period between 2 and 6 pm. Pair-matched WT animals from the
same or the next litter underwent the same procedure. In total 61 an-
imals (Table S1) were included in the four groups; fasted or fed
homozygotes (15 and 14, respectively) and WT (15 and 17, respec-
tively). The weight of mutant mice was lower (mean ± SD in females
8.1 ± 0.9 g and males 9.7 ± 1.1 g) than that of WT mice (females
12.6 ± 1.6 g and males 15 ± 1.7 g). At least 5 animals per group were
used for the assessments (histology, plasma insulin, respirometry, gene
expression, lipid studies and electron microscopy). Additional 17 nor-
mally fed animals (7 homozygotes and 10 WT, P27–28) were included
for blood sampling with cardiac puncture for paraoxonase-1 (PON-1)
analysis. To assess lipase activities, additional 12 normally fed mice (6
homozygotes, 6 WT, age P27) were used to assess lipase activities from
post-heparin plasma samples obtained with cardiac puncture 15min
after intraperitoneal injection of 0.1 IU heparin per g body weight.
Total number of animals used was 90.
Before and after fasting, a tail blood sample was obtained during
transient anesthesia with isoflurane (Forene, AbbVie AB, Solna,
Sweden). The animals were sacrificed using cervical dislocation after
the second tail blood sampling, the weight was measured, and a third
blood sample was obtained by immediate heart puncture. Liver tissue
was collected directly thereafter. Plasma or serum samples were pre-
pared and frozen at −80 °C until further use. Liver tissue samples were
processed according to 4 specific protocols; 1) snap frozen at−80 °C, 2)
fixed in 4% buffered formalin, 3) collected in EM fixation buffer or 4)
soaked in ice cold isolation buffer for mitochondrial isolation.
2.2. Ethics statement
Animal experiments were performed with the approval of the Lund
regional animal research committee, Sweden (permits, M245-11,
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M337-12, 31-8265/08) according to national regulations and ARRIVE
recommendations. All efforts were taken to ameliorate suffering.
2.3. Measurements of ketone bodies, glucose and lactate in whole blood
Blood chemistry was measured from tail blood using test strips:
glucose with FreeStyle Freedom (Abbott Diabetes Care Inc., Alameda,
CA, USA), ketone bodies with Precision Xceed (Abbott Diabetes Care
Inc., Alameda, CA, USA) and lactate with Lactate Pro (ARKRAY Inc.,
Kyoto, Japan).
2.4. Insulin measurement and HOMA-IR index calculation
Plasma insulin concentrations were analyzed in duplicates using
Ultra Sensitive Mouse Insulin ELISA Kit (Crystal Chem #90080) with
low-range assay mode (according to the manufacturer's instructions)
using plasma samples obtained by cardiac puncture. Absorbance values
were measured with the Varioskan Flash Multimode Reader (Thermo
Scientific) and analyzed using the accompanying software. The home-
ostasis model assessment for insulin resistance (HOMA-IR) was calcu-
lated as the product of the fasting blood glucose value (measured in
mmol/l) and the fasting plasma insulin value (measure in mU/l) di-
vided by 22.5 [23].
2.5. Histology
Formalin-fixed liver samples were processed according to standard
pathology laboratory routine and paraffin embedded. Sections were
stained with hematoxylin and eosin (H&E) for morphology and periodic
acid–Schiff (PAS) with and without diastase for glycogen. Standard Oil-
Red-O (ORO) staining for triglycerides was performed on snap frozen
liver tissue sections.
2.6. Isolation of mouse liver mitochondria
Liver tissue, collected in isolation buffer (320mM Sucrose, 10mM
Tris, 2 mM EGTA, pH 7.4 on ice), was homogenized in 2ml of the buffer
supplemented with 0.1% bovine serum albumin. Mitochondria were
prepared from homogenates by sequential centrifugation including
density purification on 19% Percoll (GE Healthcare, Amersham, UK)
[24]. Mitochondrial protein concentrations were estimated by mea-
suring 280 nm absorbance using a Nanodrop® spectrophotometer
(Fisher Scientific, Gothenburg, Sweden).
2.7. Lipid analyses
Cellular lipids were extracted from snap-frozen liver samples by the
Folch method [25] and triglycerides were measured as glycerol after
chloroform–methanol extraction and hydrolysis. Briefly, liver tissue
(50–100mg) was mechanically homogenized and sonicated in 1ml
95% methanol and mixed with 2ml chloroform. The organic phase was
washed twice with 0.9% NaCl solution and dried under nitrogen. The
residuals were dissolved in 200 μl of tetraethylammoniumhydroxide
(diluted 1:28 with 95% ethanol (v:v)) and incubated at +60 °C for
30min in the presence of added 200 μl of 0.05M HCl. The formed
glycerol was measured enzymatically using a commercial triglyceride
analysis kit (GPO-PAP 1488872, Roche Diagnostics, Mannheim, Ger-
many).
Total cholesterol and choline-containing phospholipids (PC, lyso-
PC, SM) were measured from the solvent phase after initial chlor-
oform–methanol extraction, using the commercial enzymatic assays
(Cholesterol CHOD-PAP kit (Roche Diagnostics, Mannheim, Germany)
and Phospholipids B kit (Wako Chemicals, Osaka, Japan)).
Plasma free FA concentrations were measured by an enzymatic
colorimetric method (NEFA-HR(2), Wako Chemicals, Osaka, Japan).
Plasma concentration of glycerol was determined by an enzymatic
colorimetric assay (Free glycerol FS, DiaSys, Diagnostic Systems GmbH,
Holzheim, Germany).
Plasma phospholipids (choline-containing phospholipids, i.e. phos-
phatidylcholine (PC), lysoPC and sphingomyelin) were analyzed using
the Phospholipids B kit (Wako Chemicals, Osaka, Japan) or Pureauto S
PL-kit (Daiichi Pure Chemicals, Tokyo, Japan); triglycerides using the
Triglycerides GPO-PAP-kit (Roche Diagnostics, Mannheim, Germany);
free cholesterol using the Wako Free Cholesterol C kit (Wako
Chemicals, Osaka, Japan) and total cholesterol using the Cholesterol
CHOD-PAP kit (Roche Diagnostics, Mannheim, Germany).
2.8. Plasma lipoprotein analyses
Mouse plasma apolipoprotein A-I (apoA-I) was quantified using a
sandwich enzyme-linked immunosorbent assay (ELISA) as described
[26].
Plasma lipoproteins were fractionated on Superose 6 HR 10/30 size-
exclusion chromatography column (GE Healthcare, Buckinghamshire,
UK) using fast-protein liquid chromatography system (FPLC; Merck-
HPLC System) as described previously [27].
The column was operated at room temperature and was equilibrated
with a 10mM Na-phosphate/140 mM NaCl buffer, pH 7.4. Samples of
110–150 μl (mouse plasma) were applied on the column at a flow rate
of 0.5ml/min, and fractions (0.5 ml) were collected and analyzed for
cholesterol, triglycerides, choline-containing phospholipids and apoA-I.
2.9. Measurements of lipid metabolism-related enzyme activities
Post-heparin plasma (PHP) lipoprotein and hepatic lipase activities
(LPL and HL) were measured from normally fed mice to reveal a pos-
sible effect of the mutation using a previously described method [28].
Briefly, [Carboxyl-14C]-Triolein (S.A. 2.2 GBq/mmol, PerkinElmer) and
glyceryl trioleate (Sigma-Aldrich, Darmstadt, Germany) emulsified in
the presence of gum arabic was used as substrate. PHP samples were
incubated in the presence of the substrate and human serum (as a
source for apoC-II, LPL cofactor) for 1 h at +37 °C. The reaction was
stopped by addition of 3.25ml of methanol-chloroform-heptane
(1.41:1.25:1.00, v/v/v) and 0.75ml of 0.14M potassium carbonate/
borate buffer (H2CO3, 0.14M, K3BO3, 0.14M, pH 10.5). Hydrophilic
phase (bovine serum albumin-FAs) and hydrophobic phase (triolein)
were separated by centrifugation and radioactivity was measured from
both fractions by liquid scintillation counting (Wallac LS Counter,
Turku, Finland). To distinguish between HL and LPL activities, HL li-
polytic activity was measured in the presence of 1M NaCl, as this is
known to inhibit LPL activity but not hepatic lipase activity. Values
obtained using high salt were attributed to HL activity and LPL activity
was calculated by subtracting the HL activity from the total PHP lipo-
lytic activity. Lipolytic activity was expressed as μmol of free FAs re-
leased per hour per ml of PHP.
Phospholipid transfer protein (PLTP) activity (nmol/ml/h) was de-
termined with a radiometric method as described [29]. The intra- and
inter-assay coefficients of variability (CVs) for PLTP were 9% and 12%,
respectively. Paraoxonase-1 (PON-1) activity was measured with a
chromogenic method [30]. The intra-assay and inter-assay CVs for
PON-1 measurements were 10% and 7%, respectively.
2.10. High resolution respirometry
Oxygen consumption of freshly isolated mitochondria (protein
concentration 250 μg/ml) was measured using an Oroboros Oxygraph-
2 k equipped with the DatLab 4 software (Oroboros Instruments,
Innsbruck, Austria). Experiments were run at 37 °C in mitochondrial
respiration medium MIR05 supplemented stepwise with substrates and
inhibitors for individual complexes, using the SUIT protocol by se-
quential addition of complex I and complex II substrates, uncoupler,
and inhibitors [8,31].
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2.11. Electron microscopy
Approximately 1mm3 pieces of liver tissue samples, obtained im-
mediately after the animal was sacrificed, were fixed in 1.5% glutar-
aldehyde, 1.5% paraformaldehyde in 0.1 M Sörensen buffer pH 7.2. The
fixed samples were thereafter prepared for ultrathin sectioning and
subjected to transmission electron microscopy (TEM) according to
standard methods. Specimens were examined in a Philips/FEI CM 100
BioTWIN transmission electron microscope at 60 kV voltage. Images
were recorded with a side-mounted Olympus Veleta camera with a
resolution of 2048× 2048 pixels (2 k× 2 k).
Area, cristae number and thickness, and the shape of hepatocyte
mitochondria were determined manually from images in Adobe
Photoshop CS5. Cross sectional area was determined by manually se-
lecting the longest and shortest axis of each mitochondrion.
Approximately 100 different hepatocytes were chosen at random
locations and layers throughout at least 10 different specimen pre-
parations per animal. Around five mitochondria per hepatocyte, chosen
at random, were measured, yielding approximately 500 investigated
mitochondria per animal.
2.12. RNA isolation and quantitative PCR
RNA was extracted from snap frozen liver tissue using the RNeasy
Mini kit and RNase free DNase set according to the manufacturer's re-
commendations (Qiagen GmbH, Düsseldorf, Germany), and RNA
quantity and quality were analyzed with Nanodrop® spectrophotometer
(Fisher Scientific, Gothenburg, Sweden) and agarose gel. For cDNA
synthesis 500 ng total RNA were used with Taqman® reverse tran-
scription reagents (Fisher Scientific, Gothenburg, Sweden) using
random hexamer primers included in the kit. The resulting cDNA was
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Fig. 1. Fasting-induced changes in carbohydrate metabolism in liver and blood in homozygous Bcs1l mutant (Bcs1lp.S78G) mice and controls (WT). (A) PAS staining
for glycogen. (B) Arterial blood glucose values before and after fasting (i.e. the occasion in the linear mixed-effect model, MEM). A blood glucose concentration below
3.4mmol/l is considered hypoglycemia in mice. (C) Arterial blood lactate. Differences in values before and after fasting (B, C) are shown as differences in mean,
together with effect of fasting obtained from MEM analyses. (D) Plasma insulin concentration and (E) HOMA-IR index.
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Fisher Scientific) using Taqman Gene Expression assays (Thermo Fisher
Scientific) as listed in Table S3. Expression values were normalized
against Gapdh (Mm9999915_g1).
2.13. Statistical analysis
Linear mixed-effect models (MEMs) were used for the analysis of
responses to fast with blood glucose, ketone and lactate as outcomes.
The principal interests were to evaluate the effect of genotype (GENOT),
fasting (FAST) and occasion (OCC, defined as the timepoint before or
after fasting) on outcome variables and possible interaction between
these variables. All models were adjusted for age, weight (WG) and
litter size (LITTSIZE) describing the number of mice in the respective
animal litter. Models were also adjusted for a random effect of litter and
mouse. When there was significant interaction effect, multiple com-
parisons were carried out to check the differences, separately in cate-
gories of the variables evolved in interaction.
The general MEM used in this study may formally be described as
follows:
= ∗ + ∗ + ∗ + ∗ +
∗ + + ∗ + ∗ +
∗ ∗ + + +
OUT β FAST β OCC β GENOT β AGE β
WG β LITTSIZE β FAST OCC β
GENOT FAST OCC b b
( )
( ϵ ,
lmt lm lm lm lm
lm l lm lm
lm lm lm l lm lmt
1 2 3 4 5
6 7 12
) 0 0
where OUT is one of the outputs (GLUCOSE, ketone, lactate, L/G ratio)
for litter l, mouse m and occasion t (before or after fasting or fed period,
respectively). The estimated parameters of the model were the regres-
sion coefficients β1, β2, β3, β4, β5, β6 for each independent variable, β7,
β12 for the interactions terms, b01 and b0lm for the random effects, and
Ɛlmt the error variance.
Group comparisons for all other variables in the study were ana-
lyzed using the Kruskal-Wallis test. All analyses were conducted using
R-package version 3.5.1, except for the qPCR analysis where SPSS 22
was used to calculate Wilcoxon rank sum test. Mann-Whitney U test was
used for electron microscopy analyses. A significance level of 5% was
adopt for all tests.
3. Results
3.1. CIII deficient Bcs1lp.S78G mice respond to fasting by further hepatic
glycogen depletion and hypoglycemia
In normally fed WT mice, hepatocytes contained abundant gly-
cogen, and a 4-hour fast was sufficient to decrease the hepatic glycogen
reserves (Fig. 1A). Fed homozygous mice (Bcs1lp.S78G) showed glycogen
depletion with scattered deposits remaining, as shown previously [8,9].
Fasted homozygotes had no detectable glycogen in the liver (Fig. 1A).
Blood glucose concentration was lower in the mutant mice com-
pared to WT mice (Supplemental Table S2), independently of the oc-
casion (meaning before and after the experiment) or if they were fasted
(p= 0.003). There was a significant (p < 0.001) interaction between
fasting and occasions; glucose concentration decreased by mean
1.5 mmol/l among fasting mice (p < 0.001) and increased by
0.9 mmol/l among fed mice (p=0.016), regardless of the genotype
(Fig. 1B). No interaction was found between genotype, fasting and
occasions (genotype*fasting*occasions, p= 0.849). However, as the
baseline was lower, fasting resulted in lower blood glucose concentra-

























































Fig. 2. Fasting-induced changes in lipid metabolism in liver and blood in Bcs1lp.S78G mice. (A) ORO staining for neutral lipids. (B) Concentration of triglycerides in
liver tissue and (C) Blood ketone bodies. Differences in values before and after fasting are shown as differences in mean, together with effect of fasting obtained from
MEM analysis.
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(p < 0.001), leading to hypoglycemia (< 3.4mmol/l) in twelve out of
fourteen mutant animals, eight displaying values below 2.5 mmol/l
indicating severe hypoglycemia.
Plasma insulin concentrations in both fed and fasted mutant mice
were as low as in fasted WT (Fig. 1D). The HOMA-IR index was sig-
nificantly lower in fasted mutant mice than in fasted WT, thus ex-
cluding insulin resistance (Fig. 1E).
Blood lactate concentration in the homozygotes was similar before
(mean ± SD 4.19 ± 1.82mmol/l) and after (3.32 ± 1.17mmol/l)
fasting and the lactate to glucose ratio was significantly higher than in
WT mice, independently of fasting or occasion (Table S2). In fed ani-
mals the lactate was increased after the intervention irrespective of
genotype (Fig. 1C).
3.2. Fasting results in normal hepatic fat accumulation and ketogenesis in
Bcs1lp.S78G mice
Fasting increased hepatic neutral lipid content in WT mice, as
shown by Oil-Red-O (ORO) staining (Fig. 2A). In homozygotes, the lipid
accumulation was present already in the fed state, as previously shown
[8,9] and increased upon fasting (Fig. 2A). We quantified these findings
with tissue triglyceride measurements (Fig. 2B).
Both WT and mutant mice had a significant increase in blood ketone
(β-hydroxybutyrate) concentration after fasting (Fig. 2C). However, on
average the mutant mice had a significantly smaller increase in the
circulating ketone bodies than the WT mice.
3.3. Fasting induces normal lipid mobilization in Bcs1lp.S78G mice
Fasting resulted in increased free FA concentration in plasma in
both mutant and control mice (Fig. 3A). Glycerol, the other product of
triglyceride hydrolysis in adipose tissue, was highly increased in plasma
of WT mice by fasting. Surprisingly, plasma glycerol remained low in
the Bcs1lp.S78G mice (Fig. 3B), despite similar increase in free FAs,
suggesting rapid clearance from plasma.
Plasma concentrations of triglycerides, choline-containing phos-
pholipids, cholesterol, and apolipoprotein A1 were similar in homo-
zygous and WT mice, with no significant differences between fed and
fasted groups (Fig. 3C–F). Activity of PLTP, a mediator of net transfer
and exchange of phospholipids between different lipoproteins, was also
similar in the four groups (Fig. 3H). We also assessed lipoprotein pro-
files in fasted and fed mutant and WT mice. No clear differences were
found in the distribution of major lipoproteins, i.e. VLDL, LDL and HDL
in mutant mice. In WT mice, however, fasting resulted in an increase of
HDL levels (Fig. S1). Hepatic (HL) and lipoprotein lipase (LPL) activities
were assessed in post-heparin plasma samples using radiometric
method where free FA liberation from the substrate is quantified. No
effect of the mutation was found on the lipase activities (Fig. 3G).
Activity of paraoxonase 1 (PON1), an enzyme that is synthesized in
liver, bound to HDL particles in circulation and considered as an im-
portant circulating antioxidant, was significantly decreased in mutant
animals (Fig. 3I).
3.4. Liver mitochondria of Bcs1lp.S78G mice can adjust respiration and
ultrastructure in response to fasting despite severe CIII dysfunction
High-resolution respirometry (Fig. 4) of isolated liver mitochondria
showed that complex I related phosphorylating states were similar in
fed WT and mutant mice. Oligomycin induced (complex V inhibition)
non-phosphorylating respiration rates (LEAK) were lower in mutant
mice. Fasting had a general (apparent in practically all respiratory
states) enhancing effect on respiration and this was most prominent in
mutant mice and for non-phosphorylating respiration rates. To detect
the CIII deficiency in the mutant mice in respirometry both complex I
and II substrates were needed, as complex I-linked respiration is not
necessarily affected [8,11].
Mitochondria are dynamic organelles that adapt their ultrastructure
upon fasting [32]. Electron microscopy showed typical morphological
changes (increased cross-sectional area, elongation, increased distance
between cristae and crista thickness, number of cristae per mitochon-
drion) in WT mitochondria after 4 h of fasting (Fig. 5A). Fed mutant
mice had more elongated mitochondria and less cristae than WT. In
addition, mutants had less ribosomes and less endoplasmic reticulum
(ER) compared to WT (Fig. 5B). Fasting in mutants resulted in addi-
tional elongation and swelling as shown by cross sectional area, in-
creased cristae distance and thereby less cristae (Fig. 5C).
3.5. Hepatic gene expression reveals largely normal transcriptional response
to fasting in Bcs1lp.S78G mice
Main metabolic controllers and downstream genes involved in me-
tabolic switch upon fasting were analyzed using qPCR (Table S3). The
4-hour fast was enough for WT animals to switch on upregulation of the
main metabolic controllers nicotinamide phosphoribosyltransferase
(Nampt), PGC-1α (Ppargc1α), CREB Regulated Transcription
Coactivator (Crtc2) and sirtuins (Sirt1, Sirt3). The effect was also clear
on downstream key enzymes of the metabolic pathways: gluconeo-
genesis (Pck1), ketogenesis (Hmgcl), alanine metabolism (Alat) and β-
oxidation (Acox1, Cpt1a). Fed mutant mice had a significant upregu-
lation of Ppargc1a (6.4-fold increase compared to WT), Crtc2, Sirt1 (2.3-
fold), Pparγ (6.2-fold), Fgf21 (6.5-fold), Pck1, Cd36 (4.5-fold) and a
significant decrease in FA synthase (Fasn 0.3 of WT). A further upre-
gulation in response to fasting was only seen in Ppargc1a (2.5-fold),
whereas Fasn was significantly downregulated (0.5 of fed mutant level).
Additional upregulated genes in fasted mutants were the main energy
and nutrient sensor 5′-AMP-activated protein kinase (Prkag2, 1.7-fold),
beta-oxidation genes (Acox1 1.9-fold and Cpt1a 2-fold), alanine meta-
bolism (Alat 2.1-fold), Namt (1.5-fold), and mitochondrial uncoupling
protein 2 (Ucp2, 2.2-fold). However, there was no significant change in
the gene expression of the key carbohydrate gluconeogenic enzyme
(Pck1). AldoB, an enzyme operating in both directions was slightly
upregulated (1.4-fold) in mutants in response to fasting, but the key
ketogenic enzyme HMG-CoA lyase was not.
4. Discussion
In mitochondrial respiratory chain (RC) deficiencies, also referred to
as OXPHOS disorders, ATP synthesis by oxidative phosphorylation is
compromised. Subsequently, the deranged energy metabolism typically
manifests in skeletal muscle, heart or central nervous system, but can
also lead to liver disease with severe neonatal metabolic crisis, such as
in CIII deficient GRACILE syndrome patients. Due to the defective
oxidative energy metabolism, these patients and Bcs1lp.S78G mice car-
rying the patient mutation apparently utilize their hepatic glycogen
reserves for glycolysis, resulting in glycogen depletion and fasting-like
state [5,6,8–10]. The main aim of this study was to assess if the cano-
nical response to nutrient deprivation, i.e. switch to glycogenolysis and
then to fatty acid utilization, is intact in the CIII deficient mice
Bcs1lp.S78G mice. For this investigation, we selected the age window
P25–28, well before end-stage disease to avoid death due to hypogly-
cemia. The short 4-hour fast was sufficient to completely deplete liver
glycogen and induce ketogenesis in both WT and mutant animals. In a
study using different durations of fasting in P70 old mice, a 4-hour fast
resulted in a similar increase in free FAs, glycerol and ketones as in our
WT animals [33]. Therefore, we conclude that the 4-hour fast was
sufficient for investigation of the physiological response to fasting but
avoided adverse effects to the sick mice. For practical reasons the ani-
mals were fasted in afternoon, which might have resulted in a smaller
effect than if fasted during night, when they are more active and need
more energy.
Surprisingly, albeit the Bcs1l mutants are growth restricted with
chronic starvation-like state [8,9], with significant upregulation of
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hepatic Ppargc1a, Sirt1 and Fgf21 expression [34], they were able to
induce further lipolysis in response to fasting as shown by increased
plasma free FAs. Since we observed no increase in LPL activity and low
insulin levels, insulin being a master regulator of LPL [35], our data
indicate that the free FAs were derived from normal route, i.e. TG-lipid
droplet lipolysis in adipose tissue. In line with the increased liver lipid
content, increased hepatic expression of the fatty acid receptor Cd36
[36] suggested increased uptake of circulating FAs into hepatocytes.
Concomitantly, hepatic fatty acid synthase (Fasn) expression was de-
creased, which is a well-known response to fasting [33,37]. Moreover,
fasting-induced upregulation of the key genes involved in beta-oxida-
tion and ketogenesis, Acox1 and Cpt1a, in both mutant and WT animals
suggested that the mutants could induce transcriptional response for
utilization of circulating free FAs to compensate for glucose deficiency
[38,39]. In our previous study, high-fat, low-carbohydrate ketogenic
diet had a beneficial effect on liver histology and mitochondrial ultra-
structure in Bcs1lp.S78G mice [40]. Although the mechanism of this
improvement remained unclear, the study suggested that the mice
could normally utilize fatty acid β-oxidation for energy production in
the absence of glucose. In the current study, the strikingly low plasma
glycerol in the mutants most probably resulted from a rapid uptake of
glycerol into hepatocytes, in which glycerol is metabolized for gluco-
neogenesis and also provides reducing substrates for mitochondria
[18]. This may have contributed to the improved total respiratory ca-
pacity we observed in fasted homozygotes. In our previous metabo-
lomics study of liver tissue, dihydroxyacetonephosphate and 3-
phospho-glyceraldehyde concentrations were decreased at all studied
ages, P14, P24, and P30 [41] supporting that glycerol was used for
gluconeogenesis.
PPARα is a master transcriptional regulator of liver intermediary
metabolism and is needed in newborn mice for ketogenesis and glycerol
utilization for gluconeogenesis [42]. Pparα was only slightly upregu-
lated in fasted WT but not in homozygotes. This is in line with a study
on adult C57BL/6J mice, where a 4-hour fast did not increase Pparα
expression, but after 16 h 4-fold upregulation was observed [43]. In a
study assessing gene expression after 24 and 48 h of fasting in 129/SV
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Fig. 3. Effect of fasting on plasma lipids, glycerol and lipase activities in Bcs1lp.S78G mice. Concentration of (A) plasma free fatty acids, (B) glycerol, (C) triglycerides,
(D) cholesterol, (E) phospholipids and (F) apoA-I in fed and fasted mice. (G) Activities of lipoprotein lipases (LPL) and hepatic lipases (HPL) in post-heparin plasma.
(H) Plasma phospholipid transfer protein (PLTP) activity and (I) serum PON-1 activity. Significant differences are indicated (p-values from Kruskal-Wallis test).
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mice at 8–15weeks of age, no change in Pparα expression was observed
[37], whereas in C57BL/6 mice subjected to fasting at P70, the main
genes showing increased expressions were Gdf15, Pparα, Pgc1α, Fgf21,
Acox1, Hmgc2 and Cpt1a [39], mainly in line with our findings.
We found very few changes in plasma lipid and lipoprotein levels in
fed homozygotes, and also post-heparin LPL and HL activities were si-
milar to those of controls. Only PON1 activity was significantly lower in
homozygotes. PON1 is a glycoprotein, mainly synthesized by the liver
and circulates bound to HDL particles [44]. It protects LDL from oxi-
dative stress and plays a role in maintaining a low oxidative state in
blood circulation [45]. Low PON-1 activity in homozygotes would
suggest attenuated anti-oxidant capacity in circulation and thereby at-
tenuated atheroprotection. What is the role of PON-1 regulation in the
mutant mice remains to be clarified in more detail in future studies.
Finally, fasting increased mitochondrial respiratory capacity in
homozygotes more than in WT. In a study using intermittent (every
second day) fasting, increased mitochondrial respiratory capacity was
found in liver, but not in brain, heart or skeletal muscle [46]. The
mechanism by which fasting increases respiration has not been clar-
ified. Morphologically we noted clear changes in mitochondrial shape
and in cristae number and distances, indicating that also the regulation
of mitochondrial morphology by 4-hour fasting was preserved despite
severe CIII deficiency.
5. Conclusion
The present study shows that systemic lipid mobilization and utili-
zation mechanisms were functional in CIII deficient Bcs1l mutant mice,
and the mice were able to respond to fasting despite their severe hy-
poglycemia and chronic energy deficiency. Our results are in line with
the current understanding of the pathogenesis of GRACILE syndrome,
with liver and kidney being the primary affected organs and the im-
balance in systemic energy metabolism and loss of WAT a consequence
of these pathologies.
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Fig. 4. Effect of fasting on respiration in
Bcs1lp.S78G liver mitochondria. Oxygen con-
sumption of isolated liver mitochondria from
fed or fasted (A) wild-type or (B) mutant mice
was determined using an oxygraph.
Phosphorylating CI-driven respiration (ADP)
was induced by adding malate, pyruvate and
ADP. For maximal CI-driven phosphorylating
respiration (CI), glutamate was added.
Maximal substrate-dependent respiration (CI&
CII) was obtained by subsequently adding CII
substrate succinate. Basal non-phosphor-
ylating respiration (LEAK) was evaluated with
oligomycin. The capacity of the electron
transport system (ETS CI&CII and ETS CII) was
obtained by titrating with the protonophore
FCCP and subsequent inhibition of CI by ro-
tenone. Bars represent means and whiskers SD,
significances analyzed with Kruskal-Wallis
test.
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Fig. 5. Effect of fasting on mitochondrial morphology in hepatocytes of Bcs1lp.S78G mice. (A) Representative electron micrographs of hepatocytes (M, mitochondria; L,
lipid droplets; N, nucleus) and (B) zoom-in to show endoplasmic reticulum (ER) and mitochondria interaction, and (C) quantification of parameters related to
mitochondrial morphology at two ages, P26 and P27. The numbers represent data range or mean and standard deviation. Statistics: Mann-Whitney U test. p < 0.05,
p < 0.01, p < 0.001, p < 0.0005 (*, **, *** and **** vs fed WT).
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